Sagimet Biosciences
SGMT
SGMT
67 hedge funds and large institutions have $89M invested in Sagimet Biosciences in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6.84% less ownership
Funds ownership: 44.9% → 38.06% (-6.8%)
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
Holders
67
Holding in Top 10
2
Calls
$3.95M
Puts
$2.24M
Top Buyers
| 1 | +$19.5M | |
| 2 | +$2.2M | |
| 3 | +$2.05M | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$1.13M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.1M |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$4.26M | |
| 3 | -$3.89M | |
| 4 |
BlackRock
New York
|
-$3.72M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.57M |
